2019

Pharmacy Fraud Within Pharmaceutical Co-Pay Programs: What You Need to Know

On a single day in early January 2019, TrialCard Incorporated’s Pharmacy Fraud Detection team identified and blocked three pharmacies engaged in fraudulent behavior associated with pharmaceutical co-pay programs. These pharmacies submitted claims for payment on expensive prescriptions that were never filled or distributed to patients. Fortunately, TrialCard was able to intercept the fraudulent transactions on the same day they were submitted, thereby saving our client nearly $2 million. Had these claims gone through, the brand’s reimbursement budget for the entire year would have been exhausted. These are not isolated incidents. TrialCard discovers an average of five fraudulent pharmacies per [...]

2019-02-20T14:25:39+00:00February 15th, 2019|

Law and Order: Pharmacy Fraud Unit

I really wanted to begin this blog post with some cheesy line that sounded like the opening monologue of Law and Order (the original, thank you, not one of the 400 spin-offs) but, I will spare you. Fraud is here. It's always been here, to be honest, but now it's taken on an entirely new form. We are not just dealing with what I like to call the "monthly bonus" pharmacy owner who processed one or two fraudulent claims a month. Nope. We have graduated to the big leagues. Now, we see pharmacies open for less than a month, [...]

2019-02-06T14:08:43+00:00February 6th, 2019|

TrialCard Continues Growth Trend with Acquisition of RxSolutions

MORRISVILLE, NC—TrialCard Incorporated, an industry leader in access, affordability, adherence, and engagement solutions for patients and healthcare providers, today announced the acquisition of RxSolutions, a company that specializes in customized pharmaceutical reimbursement programs for both commercial and clinical supply professionals. In addition to traditional pharmaceutical co-pay programs, RxSolutions has introduced the RxStudy Card™, a revolutionary way to streamline supply management for pharmaceutical manufacturers conducting clinical trials. The RxStudy Card saves the sponsor one-third or more of the cost of open-label study components by allowing patients to obtain unblinded medications and supplies at trusted retail and specialty pharmacies. The acquisition will [...]

2019-01-17T08:54:50+00:00January 17th, 2019|